Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,361
Recruiting: 790
Ph III recruiting: 74
Growth YoY: +9.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (646)

clinicaltrialsPublishedShowing 251–300 of 1,002 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07704489	San Raffaele Registry on Liver Cancer	recruiting	—	4,000	IRCCS San RaffaeleOTHER	1	Jul 15, 2026	clinicaltrials
NCT05669339	AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma	recruiting	Phase 2	12	University of FloridaOTHER	1	Jul 14, 2026	clinicaltrials
NCT06340646